Asclepius: a new CRO for clinical trials in Russia

The success of clinical trials brings new challenges that Asclepius is committed to answering. The members of our team have worked in a number of global CROs and have taken on board the best experience of the existing crop of CROs that are present in Russia.
 
Our experience tells us there is tremendous potential still to be tapped in Russian clinical trials, thanks to large patient populations that have yet to enter clinical trials, the scope for further integration with the global market and, last but not least, the opportunities that our own professional development opens up.

The acid test of the health of the clinical trials industry in realizing this potential lies in our ability to improve every dimension of the process: improving informed patient consent, developing a more active role in communicating with our international partners, and encouraging investigators, monitors and managers alike to value the role every member of our team plays.

We are confident at Asclepius that we have the necessary leadership qualities to take the industry forward.